Ekhlass Mohammed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ekhlass Mohammed has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Sania Al Hamad
Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE
2 shared publications Aboma Zewude
1 shared publicationAhmed Alsuwaidi
1 shared publication- Asha Antony
Department of Veterinary Medicine College of Agriculture and Veterinary Medicine United Arab Emirates University Al Ain UAE
1 shared publication Atef Oreiby
1 shared publication- Balázs Ádám
Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by Elsevier in Next Research
- Vol. 11
Q Fever in the United Arab Emirates and in other Gulf Cooperation Council States: A Neglected Zoonosis Requiring a One Health Policy Response
- 2 July 2026
- Published by Elsevier in Next Research
- Vol. 11
Open AccessQ Fever in the United Arab Emirates and in other Gulf Cooperation Council States: A Neglected Zoonosis Requiring a One Health Policy Response
- Open Access
- 30 April 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (2) , 119-128
Subclinical inflammation in children with Down syndrome: implications for preventive care
Purpose: Down syndrome (DS) is associated with metabolic dysregulation, obesity, and increased risk of chronic inflammation. This study aimed to assess subclinical inflammation in children with DS by evaluating inflammatory biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), and their association with metabolic parameters including ghrelin, lipid profiles, and vitamin D levels.Methods: A total of 49 children with DS (aged 1–18 years) and 22 age-matched healthy controls were enrolled. Anthropometric data, body fat percentage, and metabolic parameters were assessed. Inflammatory markers (hs-CRP, apolipoprotein-B [Apo B], adiponectin), metabolic hormones (ghrelin, insulin), and lipid profiles were determined from venous blood samples. Statistical analyses included bivariate correlation, analysis of variance, and multiple linear regression to identify predictors of inflammation.Results: Children with DS exhibited significantly higher hs-CRP levels than controls (p=0.03), indicative of increased systemic inflammation. Higher hs-CRP levels were associated with older age (r=0.33, p=0.006), greater obesity (body mass index: r=0.32, p=0.011), and elevated serum insulin and low-density lipoprotein levels. Ghrelin levels correlated negatively with Apo B (r=-0.41, p<0.001) and positively with hs-CRP (r=0.30, p=0.012). Predictors of inflammation (based on hs-CRP) included older age, male sex, higher gamma-glutamyl transferase level, and a diagnosis of DS (adjusted R²=0.276).Conclusion: Children with DS are prone to metabolic inflammation, with increasing age and obesity exacerbating inflammatory responses. Clinicians should monitor and manage weight, dyslipidemia, and inflammation in this population to prevent long-term complications such as cardiovascular diseases and insulin resistance.
- 30 April 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (2) , 119-128
Open AccessSubclinical inflammation in children with Down syndrome: implications for preventive care
Purpose: Down syndrome (DS) is associated with metabolic dysregulation, obesity, and increased risk of chronic inflammation. This study aimed to assess subclinical inflammation in children with DS by evaluating inflammatory biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), and their association with metabolic parameters including ghrelin, lipid profiles, and vitamin D levels.Methods: A total of 49 children with DS (aged 1–18 years) and 22 age-matched healthy controls were enrolled. Anthropometric data, body fat percentage, and metabolic parameters were assessed. Inflammatory markers (hs-CRP, apolipoprotein-B [Apo B], adiponectin), metabolic hormones (ghrelin, insulin), and lipid profiles were determined from venous blood samples. Statistical analyses included bivariate correlation, analysis of variance, and multiple linear regression to identify predictors of inflammation.Results: Children with DS exhibited significantly higher hs-CRP levels than controls (p=0.03), indicative of increased systemic inflammation. Higher hs-CRP levels were associated with older age (r=0.33, p=0.006), greater obesity (body mass index: r=0.32, p=0.011), and elevated serum insulin and low-density lipoprotein levels. Ghrelin levels correlated negatively with Apo B (r=-0.41, p<0.001) and positively with hs-CRP (r=0.30, p=0.012). Predictors of inflammation (based on hs-CRP) included older age, male sex, higher gamma-glutamyl transferase level, and a diagnosis of DS (adjusted R²=0.276).Conclusion: Children with DS are prone to metabolic inflammation, with increasing age and obesity exacerbating inflammatory responses. Clinicians should monitor and manage weight, dyslipidemia, and inflammation in this population to prevent long-term complications such as cardiovascular diseases and insulin resistance.